Literature DB >> 205879

Protein kinase activity associated with the avian sarcoma virus src gene product.

M S Collett, R L Erikson.   

Abstract

Incorporation of phosphorus from [gamma-32P]ATP into protein was catalyzed by specific immunoprecipitates from avian sarcoma virus (ASV)-transformed avian and mammalian cells. This incorporation was observed only when antiserum from tumor-bearing rabbits able to specifically precipitate the ASV sarcoma gene product, p60src, was used to immunoprecipitate antigens from transformed cell lysates. Immunoprecipitates of extracts from normal cells or cells infected with a transformation-defective ASV mutant showed no activity in this assay, nor did any immune complexes formed with normal rabbit serum and any of the cell extracts tested. The expression of the protein kinase activity (ATP:protein phosphotransferase, EC 2.7.1.37) was growth temperature-dependent in cells infected with an ASV mutant temperature-sensitive for the transformation. These results on an enzymatic activity associated with the ASV transforming protein are discussed in terms of protein phosphorylation as a mechanism for viral transformation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 205879      PMCID: PMC392475          DOI: 10.1073/pnas.75.4.2021

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  Protein phosphorylation.

Authors:  C S Rubin; O M Rosen
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses.

Authors:  D Stehelin; R V Guntaka; H E Varmus; J M Bishop
Journal:  J Mol Biol       Date:  1976-03-05       Impact factor: 5.469

3.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

4.  Translation of 35S and of subgenomic regions of avian sarcoma virus RNA.

Authors:  A F Purchio; E Erikson; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

5.  Characteristics of virus-specific RNA in avian sarcoma virus-transformed BHK-21 cells and revertants.

Authors:  C T Deng; D Stehelin; J M Bishop; H E Varmus
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

6.  Reversion from transformed to normal phenotype by inhibition of protein synthesis in rat kidney cells infected with a temperature-sensitive mutant of Rous sarcoma virus.

Authors:  J F Ash; P K Vogt; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

7.  Antibody to virion structural proteins in mammals bearing avian sarcoma virus-induced tumors.

Authors:  J S Brugge; E Erikson; R L Erikson
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

8.  Mapping RNase T1-resistant oligonucleotides of avian tumor virus RNAs: sarcoma-specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly(A) end.

Authors:  L H Wang; P Duesberg; K Beemon; P K Vogt
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

9.  Properties of mammalian cells transformed by temperature-sensitive mutants of avian sarcoma virus.

Authors:  Y C Chen; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-07       Impact factor: 41.582

10.  On the mechanism of ATP-induced shape changes in human erythrocyte membranes. II. The role of ATP.

Authors:  W Birchmeier; S J Singer
Journal:  J Cell Biol       Date:  1977-06       Impact factor: 10.539

View more
  367 in total

1.  No activation of new initiation points for deoxyribonucleic acid replication in BALB/c 3T3 cells transformed by Kirsten sarcoma virus.

Authors:  A Oppenheim; A T Horowitz
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides.

Authors:  K Radke; G S Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

3.  Characterization of the protein kinase activity of avian sarcoma virus src gene product.

Authors:  P F Maness; H Engeser; M E Greenberg; M O'Farrell; W E Gall; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

4.  Fractionation of two protein kinases from avian myeloblastosis virus and characterization of the protein kinase activity preferring basic phosphoacceptor proteins.

Authors:  M J Rosok; K F Watson
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

5.  Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src).

Authors:  H Oppermann; A D Levinson; H E Varmus; L Levintow; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Inhibition of v-src-induced transformation by a GTPase-activating protein.

Authors:  M Nori; U S Vogel; J B Gibbs; M J Weber
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

Review 7.  Chemical carcinogenesis -- the price for DNA - repair?

Authors:  U Wintersberger
Journal:  Naturwissenschaften       Date:  1982-03

Review 8.  Src signaling pathways in prostate cancer.

Authors:  Andreas Varkaris; Anastasia D Katsiampoura; John C Araujo; Gary E Gallick; Paul G Corn
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

9.  Overexpression of src family gene for tyrosine-kinase p59fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder.

Authors:  T Katagiri; K Urakawa; Y Yamanashi; K Semba; T Takahashi; K Toyoshima; T Yamamoto; K Kano
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 10.  Evolution of a dynamic molecular switch.

Authors:  Susan S Taylor; Hiruy S Meharena; Alexandr P Kornev
Journal:  IUBMB Life       Date:  2019-05-06       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.